Showing results (81-90 of 279) with videos related to
Sort By:
Pageof 28
The Journal of Experimental Medicine|May 1, 1975
The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b)J D Gitlin, F S Rosen, P J LachmannComplement and Inflammation|January 1, 1989
Complotypes and extended haplotypes in laboratory medicineC A Alper, Z L Awdeh, E J YunisClinical Immunology and Immunopathology|April 1, 1991
Decreased inhibition of immune precipitation by sera with the C2 B allotypeL Varga, C A Alper, Z Zam, et al.The Journal of Experimental Medicine|May 1, 1976
Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminaseJ J Ballet, R Insel, E Merler, et al.Blood|July 1, 1987
Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndromeE Remold-O'Donnell, C Zimmerman, D Kenney, et al.The Journal of Clinical Investigation|March 1, 1987
Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edemaM Cicardi, T Igarashi, F S Rosen, et al.The Journal of Experimental Medicine|November 1, 1973
Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytesR S Geha, E Schneeberger, F S Rosen, et al.The Journal of Clinical Investigation|December 1, 1981
Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patientsR Hirschhorn, V Roegner-Maniscalco, L Kuritsky, et al.Lancet (London, England)|June 9, 1979
Genetic marker for insulin-dependent diabetes mellitusD Raum, C A Alper, R Stein, et al.Immunogenetics|March 31, 2012
Genetic polymorphism of serum complement components in the chimpanzeeD Raum, H Balner, B H Petersen, et al.Pageof 28